연구동향 분석

급성허혈뇌졸중 환자의 초기 혈중 요산농도와 발병3개월 후 기능예후와의 연관성

변소영 김영은 오미선 유경호 김보희 이은주 이병철 2014년

논문상세정보
인용/피인용
' 급성허혈뇌졸중 환자의 초기 혈중 요산농도와 발병3개월 후 기능예후와의 연관성' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 내과학
  • cerebralinfarction
  • cerebrovasculardisorders
  • myocardial infarction
  • outcome assessment
  • uric acid
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
1,564 0

0.0%

' 급성허혈뇌졸중 환자의 초기 혈중 요산농도와 발병3개월 후 기능예후와의 연관성' 의 참고문헌

  • 한국 뇌졸중 자료은행에 등록된 10,811명의 급성기 허혈성 뇌졸중 환자 분석: 병원기반 다의료기관 전향적 자료등록 연구
    유경호 대한신경과학회지 24 (6) : 535 ~ 543 [2006]
  • 한국 뇌졸중 자료은행에 등록된 10,811명의 급성기 허혈성 뇌졸중 환자 분석: 병원기반 다의료기관 전향적 자료등록 연구
    유경호 대한신경과학회지 24 6 535-543 [2006]
  • 중등도 이상 허혈성 뇌졸중 환자의 뇌졸중 아형에 따른 요산과 조기 예후와의 관계
    김준현 대한신경과학회지 28 (3) : 149 ~ 156 [2010]
  • 중등도 이상 허혈성 뇌졸중 환자의 뇌졸중 아형에 따른 요산과 조기 예후와의 관계
    김준현 대한신경과학회지 28 3 149-156 [2010]
  • Xanthine oxidase inhibition for the treatment of stroke disease: a novel therapeutic approach
    Higgins P Expert Rev Cardiovasc Ther 9 : 399 ~ 401 [2011]
  • Xanthine oxidase inhibition for the treatment of stroke disease: a novel therapeutic approach
    Higgins P Expert Rev Cardiovasc Ther 9 399-401 [2011]
  • Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2
    Kanellis J Hypertension 41 : 1287 ~ 1293 [2003]
  • Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2
    Kanellis J Hypertension 41 1287-1293 [2003]
  • Uric acid reduction: a new paradigm in the management of cardiovascular risk?
    Dawson J Curr Med Chem 14 : 1879 ~ 1886 [2007]
  • Uric acid reduction: a new paradigm in the management of cardiovascular risk?
    Dawson J Curr Med Chem 14 1879-1886 [2007]
  • Uric acid reduces brain damage and improves the benefits of rt-PA in a rat model of thromboembolic stroke
    Romanos E J Cereb Blood Flow Metab 27 : 14 ~ 20 [2007]
  • Uric acid reduces brain damage and improves the benefits of rt-PA in a rat model of thromboembolic stroke
    Romanos E J Cereb Blood Flow Metab 27 14-20 [2007]
  • Uric acid as a cardiovascular risk factor in arte-rial hypertension
    Puig JG J Hypertens 17 : 869 ~ 872 [1999]
  • Uric acid as a cardiovascular risk factor in arte-rial hypertension
    Puig JG J Hypertens 17 869-872 [1999]
  • Uric acid and xanthine oxidase: future ther-apeutic targets in the prevention of cardiovascular disease?
    Dawson J Br J Clin Pharmacol 62 : 633 ~ 644 [2006]
  • Uric acid and xanthine oxidase: future ther-apeutic targets in the prevention of cardiovascular disease?
    Dawson J Br J Clin Pharmacol 62 633-644 [2006]
  • Uric acid and serum antioxidant capacity: a reaction to atherosclerosis?
    Nieto FJ Atherosclerosis 148 : 131 ~ 139 [2000]
  • Uric acid and serum antioxidant capacity: a reaction to atherosclerosis?
    Nieto FJ Atherosclerosis 148 131-139 [2000]
  • Towards the physiological function of uric acid
    Becker BF Free Radic Biol Med 14 : 615 ~ 631 [1993]
  • Towards the physiological function of uric acid
    Becker BF Free Radic Biol Med 14 615-631 [1993]
  • Targets for vascular protection after acute ischemic stroke
    Fagan SC Stroke 35 : 2220 ~ 2225 [2004]
  • Targets for vascular protection after acute ischemic stroke
    Fagan SC Stroke 35 2220-2225 [2004]
  • Serum uric acid is a strong predictor of stroke in patients with non-insulin-dependent dia-betes mellitus
    Lehto S Stroke 29 : 635 ~ 639 [1998]
  • Serum uric acid is a strong predictor of stroke in patients with non-insulin-dependent dia-betes mellitus
    Lehto S Stroke 29 635-639 [1998]
  • Serum uric acid independently predicts mortality in patients with significant, angiographically defined coronary disease
    Madsen TE Am J Nephrol 25 : 45 ~ 49 [2005]
  • Serum uric acid independently predicts mortality in patients with significant, angiographically defined coronary disease
    Madsen TE Am J Nephrol 25 45-49 [2005]
  • Serum uric acid as an independent predictor of mortality in patients with angiographically proven coronary artery disease
    Bickel C Am J Cardiol 89 : 12 ~ 17 [2002]
  • Serum uric acid as an independent predictor of mortality in patients with angiographically proven coronary artery disease
    Bickel C Am J Cardiol 89 12-17 [2002]
  • Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study
    Culleton BF Ann Intern Med 131 : 7 ~ 13 [1999]
  • Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study
    Culleton BF Ann Intern Med 131 7-13 [1999]
  • Serum uric acid and out-come after acute ischemic stroke: PREMIER study
    Chiquete E Cerebrovasc Dis 35 : 168 ~ 174 [2013]
  • Serum uric acid and out-come after acute ischemic stroke: PREMIER study
    Chiquete E Cerebrovasc Dis 35 168-174 [2013]
  • Serum urate as an in-dependent predictor of poor outcome and future vascular events after acute stroke
    Weir CJ Stroke 34 : 1951 ~ 1956 [2003]
  • Serum urate as an in-dependent predictor of poor outcome and future vascular events after acute stroke
    Weir CJ Stroke 34 1951-1956 [2003]
  • Serum urate and the risk of major coronary heart disease events
    Wannamethee SG Heart 78 : 147 ~ 153 [1997]
  • Serum urate and the risk of major coronary heart disease events
    Wannamethee SG Heart 78 147-153 [1997]
  • Risk factors for extracranial carotid artery atherosclerosis
    Crouse JR Stroke 18 : 990 ~ 996 [1987]
  • Risk factors for extracranial carotid artery atherosclerosis
    Crouse JR Stroke 18 990-996 [1987]
  • Regulation of xanthine dehydrogenase and xanthine oxidase activity by hypoxia
    Poss WB Am J Physiol 270 : L941 ~ L946 [1996]
  • Regulation of xanthine dehydrogenase and xanthine oxidase activity by hypoxia
    Poss WB Am J Physiol 270 L941-L946 [1996]
  • Prognostic significance of uric acid serum concentration in patients with acute ischemic stroke
    Chamorro A Stroke 33 : 1048 ~ 1052 [2002]
  • Prognostic significance of uric acid serum concentration in patients with acute ischemic stroke
    Chamorro A Stroke 33 1048-1052 [2002]
  • On chronic Bright's disease, and its essential symptoms
    Mahomed FA Lancet 113 : 399 ~ 401 [1879]
  • On chronic Bright's disease, and its essential symptoms
    Mahomed FA Lancet 113 399-401 [1879]
  • New concepts in reactive oxygen species and cardiovascular reperfusion physiology
    Becker LB Cardiovasc Res 61 : 461 ~ 470 [2004]
  • New concepts in reactive oxygen species and cardiovascular reperfusion physiology
    Becker LB Cardiovasc Res 61 461-470 [2004]
  • Myocardial malondialdehyde and uric acid release after short-lasting coronary occlusions during coronary angioplasty: po-tential mechanisms for free radical generation
    De Scheerder IK Am J Cardiol 68 : 392 ~ 395 [1991]
  • Myocardial malondialdehyde and uric acid release after short-lasting coronary occlusions during coronary angioplasty: po-tential mechanisms for free radical generation
    De Scheerder IK Am J Cardiol 68 392-395 [1991]
  • Measurements of acute cerebral infarction: a clinical examination scale
    Brott T Stroke 20 864-870 [1989]
  • Measurements of acute cerebral infarction : a clinical examination scale
    Brott T Stroke 20 : 864 ~ 870 [1989]
  • Lack of association between serum uric acid levels and out-come in acute ischemic stroke
    Miedema I J Neurol Sci 319 : 51 ~ 55 [2012]
  • Lack of association between serum uric acid levels and out-come in acute ischemic stroke
    Miedema I J Neurol Sci 319 51-55 [2012]
  • Is elevated SUA associated with a worse outcome in young Chinese patients with acute cerebral ischemic stroke?
    Zhang B BMC Neurol 10 : 82 ~ [2010]
  • Is elevated SUA associated with a worse outcome in young Chinese patients with acute cerebral ischemic stroke?
    Zhang B BMC Neurol 10 82- [2010]
  • Interobserver agreement for the assessment of handicap in stroke patients
    van Swieten JC Stroke 19 : 604 ~ 607 [1988]
  • Interobserver agreement for the assessment of handicap in stroke patients
    Van Swieten JC Stroke 19 604-607 [1988]
  • Influence of recanalization on uric acid patterns in acute ischemic stroke
    Hong JM Cerebrovasc Dis 29 : 431 ~ 439 [2010]
  • Influence of recanalization on uric acid patterns in acute ischemic stroke
    Hong JM Cerebrovasc Dis 29 431-439 [2010]
  • Increased plasma levels of lipid hydroperoxides in patients with is-chemic stroke
    Polidori MC Free Radic Biol Med 25 : 561 ~ 567 [1998]
  • Increased plasma levels of lipid hydroperoxides in patients with is-chemic stroke
    Polidori MC Free Radic Biol Med 25 561-567 [1998]
  • Hyperuricemia as a risk factor of coronary heart disease: The Framingham Study
    Brand FN Am J Epidemiol 121 : 11 ~ 18 [1985]
  • Hyperuricemia as a risk factor of coronary heart disease: The Framingham Study
    Brand FN Am J Epidemiol 121 11-18 [1985]
  • Hyperuricemia and risk of stroke: a systematic review and meta-analysis of prospective studies
    Li M Atherosclerosis 232 : 265 ~ 270 [2014]
  • Hyperuricemia and risk of stroke: a systematic review and meta-analysis of prospective studies
    Li M Atherosclerosis 232 265-270 [2014]
  • Decrease in uric acid in acute ischemic stroke corre-lates with stroke severity, evolution and outcome
    Brouns R Clin Chem Lab Med 48 : 383 ~ 390 [2010]
  • Decrease in uric acid in acute ischemic stroke corre-lates with stroke severity, evolution and outcome
    Brouns R Clin Chem Lab Med 48 383-390 [2010]
  • Correlates of uric acid and its association with asymptomatic carotid atherosclerosis: the ARIC Study. Atherosclerosis Risk in Communities
    Iribarren C Ann Epidemiol 6 : 331 ~ 340 [1996]
  • Correlates of uric acid and its association with asymptomatic carotid atherosclerosis: the ARIC Study. Atherosclerosis Risk in Communities
    Iribarren C Ann Epidemiol 6 331-340 [1996]
  • Comparison of neurological scales and scoring systems for acute stroke prognosis
    Muir KW Stroke 27 : 1817 ~ 1820 [1996]
  • Comparison of neurological scales and scoring systems for acute stroke prognosis
    Muir KW Stroke 27 1817-1820 [1996]
  • Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment
    Adams HP Jr Stroke 24 : 35 ~ 41 [1993]
  • Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment
    Adams HP Jr Stroke 24 35-41 [1993]
  • Baseline serum urate and 90-day functional outcomes following acute ischemic stroke
    Dawson J Cerebrovasc Dis 28 : 202 ~ 203 [2009]
  • Baseline serum urate and 90-day functional outcomes following acute ischemic stroke
    Dawson J Cerebrovasc Dis 28 202-203 [2009]
  • Ascorbate prevents prooxidant effects of urate in oxidation of human low density lipoprotein
    Abuja PM FEBS Lett 446 : 305 ~ 308 [1999]
  • Ascorbate prevents prooxidant effects of urate in oxidation of human low density lipoprotein
    Abuja PM FEBS Lett 446 305-308 [1999]
  • A pilot study of dual treatment with recombinant tissue plasminogen activa-tor and uric acid in acute ischemic stroke
    Amaro S Stroke 38 : 2173 ~ 2175 [2007]
  • A pilot study of dual treatment with recombinant tissue plasminogen activa-tor and uric acid in acute ischemic stroke
    Amaro S Stroke 38 2173-2175 [2007]